Resveralogues protect HepG2 cells against cellular senescence induced by hepatoxic metabolites

Keyphrases

• Cellular Senescence 100%
• HepG2 Cells 100%
• Hepatotoxic 100%
• Senescence 75%
• Humanized Liver 75%
• Liver 50%
• Toxic Metabolites 50%
• Three-dimensional Culture 50%
• Sirtuin 1 (SIRT1) 50%
• D-dimensional 50%
• Two Dimensional 25%
• Small Molecules 25%
• Liver Dysfunction 25%
• Urea 25%
• Alginate 25%
• Unconjugated Bilirubin 25%
• Hepatocytes 25%
• Cryogel 25%
• Pre-incubation 25%
• Senescence-associated 25%
• β-Galactosidase (β-Gal) 25%
• Ki67 Staining 25%
• Resveratrol 25%
• Ammonia 25%
• Albumin 25%
• Population Aging 25%
• Human Use 25%
• Liver Failure 25%
• HepG2 25%
• Cell Population 25%
• Liver Disease 25%
• Albumin Synthesis 25%
• Metabolic Function 25%
• Differential Capacity 25%
• Ki-67 25%
• Growth Fraction 25%
• Bridge to Transplantation 25%
• Thymidine Analogs 25%
• Liver Transplantation 25%
• Tissue Culture System 25%
• Bridge to Recovery 25%
• Liver Function 25%
• Rapid Failure 25%
• Hepatotoxin 25%
• Culture Surface 25%
• Clinical Endpoints 25%
• Artificial Organs 25%
• Patient Plasma 25%
• Urea Synthesis 25%

Biochemistry, Genetics and Molecular Biology

• Metabolite 100%
• Blood Plasma 57%
• Cytokine 28%
• Sirtuin1 28%
• P53 14%
• P21 14%
• P16 14%
• Hepatocyte 14%
• Small Molecule 14%
• Resveratrol 14%
• Galactosidase 14%
• Alginate 14%
• Tissue Culture 14%
• Liver Function 14%
• Urea Cycle 14%
• Bilirubin 14%
• Thymidine 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Hepatotoxicity 100%
• Cytokine 33%
• Toxin 33%
• Liver Dysfunction 16%
• Bilirubin 16%
• Liver Failure 16%
• Protein P53 16%
• Resveratrol 16%
• Galactosidase 16%
• Liver Disease 16%
• Thymidine 16%
• Hepatotoxin 16%
• Alginic Acid 16%